H.R. 1628 · 118th Congress (2023–2025)
CBD Product Safety and Standardization Act of 2023
This bill requires the Food and Drug Administration (FDA) to regulate food containing cannabidiol (CBD) derived from hemp as a food additive. (The FDA has determined that food containing added CBD cannot be sold in interstate commerce.)
Under this bill, in order to be sold, a food containing CBD derived from hemp must conform with current FDA requirements pertaining to food additives or be generally recognized as safe (GRAS). (Under current law, a food additive with the GRAS designation is not subject to FDA premarket review and approval requirements.)
In addition, such a food must comply with all other relevant FDA and labeling requirements.
Such a food shall be exempt from an existing provision that prohibits the sale of a food containing an additive that is (1) an FDA-approved drug or biological product, or (2) subject to certain clinical investigations.
The FDA must issue regulations pertaining to such foods that specify (1) the maximum amount of CBD derived from hemp per serving, (2) labeling and packaging requirements, and (3) any conditions for intended use.
Show official title
To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 1628’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. H. Morgan Griffith (R-VA-9)
- Cosponsors
12 cosponsors
4 original · 8 later
4 R · 8 D
- Rep. Angie Craig (D-MN-2)· Original · Mar 17, 2023
- Rep. Glenn Grothman (R-WI-6)· Original · Mar 17, 2023
- Rep. Mark Pocan (D-WI-2)· Original · Mar 17, 2023
- Rep. Dina Titus (D-NV-1)· Original · Mar 17, 2023
- Rep. James Comer (R-KY-1)· Later · Mar 28, 2023
- Rep. Tony Cárdenas (D-CA-29)· Later · Apr 13, 2023
- Rep. David Scott (D-GA-13)· Later · Apr 25, 2023
- Rep. Andy Barr (R-KY-6)· Later · Apr 27, 2023
- Rep. Ann M. Kuster (D-NH-2)· Later · Jul 13, 2023
- Rep. Morgan McGarvey (D-KY-3)· Later · Jul 17, 2023
- Rep. Dan Crenshaw (R-TX-2)· Later · Jul 24, 2023
- Rep. Jason Crow (D-CO-6)· Later · Feb 15, 2024
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Mar 17, 2023 – Mar 24, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
CBD Product Safety and Standardization Act of 2023
Display title, Short title · Introduced in House
To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes.
Official title · Introduced in House